About us

McRoberts is an innovative and flexible organization with 25 years of experience, and one of the leaders in ambulatory monitoring of physical activity. We apply our knowledge of human movement and analysis of sensor data to facilitate simple solutions in healthcare, clinical studies and research for evaluating physical functioning. Founder and former CEO of McRoberts is Rob van Lummel. His interest in the combination of movement, technology and ICT resulted in the foundation of McRoberts in 1988. In cooperation with scientific partners, epoch-making work has been realized in the development of ambulatory monitoring of physical activity. His wife, Corinne Meurs, who has been an active physiotherapist, joined the company as VP in 2006. In September 2018, after leading our company successfully for 30 years, Rob and Corinne have decided to withdraw from daily management. A young and dynamic team has taken over and will maintain our tradition of continuous improvement and development. Rob will still contribute to strategic development as Chairman.


This is what our customers and partners say about us ...

McRoberts is an important partner for many of our translational research projects”, says Kim Delbaere, Principal Research Scientist – Falls, Balance and Injury Research Centre – at Neuroscience Research Australia. “Our research focus is on…

Read full testimonial

Kim Delbaere, PhD

Our group has been collecting data from community-dwelling older adults using devices made by McRoberts for more than 5 years”, says Aron Buchman, Professor of Neurological Sciences, Rush Alzheimer's Disease Center in Chicago. “It has been a…

Read full testimonial

Aron Buchman, MD

McRoberts is a very important partner for The Hague University of Applied Sciences”, says Willem Looije, Program Manager (The Netherlands). “Since the beginning in 1992, students of our program Human Kinetic Technology are learning and working…

Read full testimonial

Willem Looije

For several years McRoberts and I are collaborating in neuromuscular and aging research,” says Andrea Maier, Professorial Fellow Medicine and Aged Care, University of Melbourne, Australia & Hoogleraar veroudering, Vrije Universiteit Amsterdam.…

Read full testimonial

Andrea Maier, PhD, MD

As the Scientific Coordinator of Moving Beyond, I would like to express my gratitude to Dr. Rob van Lummel and the McRoberts company, for their obviously extensive engagement in the network,” says Walter Maetzler, Department for Neurodegenerative…

Read full testimonial

Walter Maetzler, PhD, MD

I read your paper in PLOS One, based on measurements made with the DynaPort MoveMonitor. Very nice work and a substantial advance in the field…

Read full testimonial

Richard Casaburi, PhD, MD

Since 2012 we have collected over 1000 weeks of gait and activity of daily living data using McRoberts devices with excellent (99%) compliance,” says Professor Stephen Lord, Senior Principal Research Fellow – Falls, Balance and Injury Research…

Read full testimonial

Stephen Lord, PhD

I began working with McRoberts in 2010, finally finding first rate engineers who also were provoked because objective measures of physical activity were not common in clinical research studies for regulatory approval of new therapies,” says Stephen…

Read full testimonial

Stephen Raymond, PhD

We love to work with McRoberts for their outstanding products and services in the area of assessment of physical functioning both in health as in patients with pulmonary diseases,” says Dr. Alex van ‘t Hul, Managing Director COPDnet, Radboudumc…

Read full testimonial

Alex van ‘t Hul, PhD

In the field of activity assessment, McRoberts was known to us from the IMI PROactive project as having a genuine scientific interest in activity assessment and openness to get involved in development of new measures and principles,” says Alan…

Read full testimonial

Alan Hamilton, PhD

2019-2024 IMI Mobilise-D

The title of the five-year project is ‘Linking digital assessment of mobility to clinical endpoints to drive regulatory acceptance and clinical practice’.

Read more All projects


Martijn Niessen, PhD Chief Executive Officer
Jordi Evers, MSc Chief Marketing Officer
Sem Lagerberg, MSc Quality Control Officer Project Manager
Erik Ainsworth, MSc Senior Software Engineer
Lucas Pluimgraaff, BSc Scrum Master Project Manager
Laura Siepman, MSc Junior Data Manager
Luca Cornelisse, MSc Account Manager Project Manager
Sietze de Haan, MSc Junior Software Engineer
Neall Mouthaan, BSc Technical Support Engineer


You can find us at the following events. Feel free to visit our booth (indicated with the icon).



29th Alzheimer Europe Conference
23 Oct, 2019
The Hague

This year the Alzheimer Europe Conference will be held in our hometown The Hague! Together with our partners from the AAL Programme PLAYTIME we will be present our integrated theratainment solution for care, rehab and diagnostics for people suffering from dementia.

Read more
IMI Mobilise-D annual meeting
18 Oct, 2019

Read more
26 Jun, 2019
Maastricht, Netherlands

The International Society for the Measurement of Physical Behaviour (ISMPB) will hold its 6th International Congress on Ambulatory Monitoring of Physical Activity and Movement (ICAMPAM) in Maastricht, The Netherlands.

Read more
2nd Annual Digital Biomarkers in Clinical Trials Summit
19 Jun, 2019
Basel, Switzerland

Building off the successful first annual event at Roche in Basel, the Digital Biomarkers in Clinical Trials Summit is the first global forum of its kind to focus on ways for pharma clinical trials to take advantage of new opportunities to collect better data and improve the patient experience; as well as how these new digital health tools supplement existing biomarker strategies.

Read more
Mobile in Clinical Trials
24 Sep, 2018
Boston, USA

This 5th Annual Mobile in Clinical Trials event presents the latest progress in applying mobile and digital tools to connect and empower patients, while obtaining better outcomes in drug development.

Read more


The MoveMonitor and MoveTest are widely used in fundamental and clinical research. Three recent studies are presented below. Browse our full list of peer-reviewed publications here.

Effects of Levodopa on quality of sleep and nocturnal movements in Parkinson’s Disease

Eva Schaeffer, Thomas Vaterrodt, Laura Zaunbrecher, Inga Liepelt-Scarfone, Kirsten Emmert, Benjamin Roeben, Morad Elshehabi, Clint Hansen, Sara Becker, Susanne Nussbaum, Jan-Hinrich Busch, Matthis Synofzik, Daniela Berg & Walter Maetzler
Feb 2021

To evaluate the effects of Levodopa and specifically the frequently used Levodopa CR on sleep, we first compared subjective rating of sleep quality in a large dataset of n > 1100 patients from three independent PD patient cohorts, allowing to stratify both an exploration cohort and two validation cohorts. Then, we explored the use of mobile health technology to compare effectively occurring movements during sleep with subjective ratings of nocturnal akinesia as well as with overall sleep quality rating, related to Levodopa intake, in one of our cohorts.

Read more

Continuous home monitoring of Parkinson’s disease using inertial sensors: A systematic review

Marco Sica, Salvatore Tedesco, Colum Crowe, Lorna Kenny, Kevin Moore, Suzanne Timmons, John Barton, Brendan O’Flynn, Dimitrios-Sokratis Komaris
Feb 2021

This review aims to collate existing literature on PD monitoring using inertial sensors while it focuses on papers with at least one free-living data capture unsupervised either directly or via videotapes.

Read more

Validity and responsiveness of the Daily- and Clinical visit-PROactive Physical Activity in COPD (D-PPAC and C-PPAC) instruments

Judith Garcia-Aymerich, Milo A Puhan, Solange Corriol-Rohou, Corina de Jong, Heleen Demeyer, Fabienne Dobbels. Damijan Erzen, Anja Frei, Elena Gimeno-Santos, Nicholas S Hopkinson, Nathalie Ivanoff, Niklas Karlsson, Zafeiris Louvaris, Michael I Polkey, Roberto A Rabinovich, Mario Scuri, Maggie Tabberer, Ioannis Vogiatzis, Thierry Troosters
Jan 2021

The objective was to test reliability, validity and responsiveness, and to define minimal important difference (MID), of the D-PPAC and C-PPAC instruments, in a large population of patients with stable COPD from diverse severities, settings and countries.

Read more
Show all publications